期刊文献+

腹腔镜保留肾单位手术治疗肾癌早期并发症临床分析 被引量:2

原文传递
导出
摘要 目的观察腹腔镜保留肾单位手术治疗T1期肾癌的效果。方法回顾性分析46例行腹腔镜保留肾单位手术治疗T1期肾癌患者的临床资料,其中经腹腔途径28例,经后腹腔途径18例,评估分析术后近期和远期并发症的发生情况。结果 46例手术均顺利完成,无中转开放,手术时间65~140min,热缺血时间16~38min,平均(24±0.8)min;术后继发性出血2例、漏尿2例、急性肾功能不全1例,淋巴管漏1例,平均随访24个月,2例术后1个月出现双肾总肾小球滤过率轻度下降,术后3个月恢复正常,46例患者均未出现局部复发及远处转移。结论腹腔镜保留肾单位手术治疗T1期肾癌安全、有效,具有较好临床应用价值。
出处 《中国煤炭工业医学杂志》 2011年第10期1444-1446,共3页 Chinese Journal of Coal Industry Medicine
  • 引文网络
  • 相关文献

参考文献10

  • 1张大宏,孙文超.保留肾单位的腹腔镜肾肿瘤切除手术方法及技巧[J].中华泌尿外科杂志,2006,27(5):332-334. 被引量:29
  • 2王林辉,陈伟,杨庆,刘冰,孙颖浩.腹腔镜保留肾单位手术治疗T_1期肾癌的临床疗效分析[J].第二军医大学学报,2010,31(6):688-690. 被引量:14
  • 3Kenichi Tobisu. Function-preserving surgery for urologic cancer[J].J Clin Oncol, 2006,11 : 351 - 356.
  • 4Fergany AF, Hafez KS, Novick AC. Long-term results of neplaron sparing surgery for localized renal cell carcinoma:10 - year follow- up[J]. J Urol,2000,163:442.
  • 5Breda A,Stepanian SV, Lain JS, et al. Use ofhaemostatic a gents and glues during laparoscopie partial nephrectomy: a multi-institutional survey from the United States and Europe ofl 347 cases[J]. Eur Uro,l 2007,52:798- 803.
  • 6Wein A J, Kavoussi LR, Novick AC, et al. Campbell - walsh Urology[M]. 9th ed. New York: Elsevier Science, 2008: 3003 - 3015.
  • 7Li QL,Cheng L,Guan HW,et al. Safety and Efficacy of Mini - Margin Nephron - Sparing Surgery for Renal Cell Carcino ma 4 - cm or Less[J]. Urology,2008,71(5) :924 - 927.
  • 8Van Poppe IH. Efficacy and safety of nephron- sparing surgery[J]. 2010,17(4) :314 - 326.
  • 9John S, Lam- Arie S, Belldegrun, et al. Long - term out comes of the surgical management of renal cell carcinoma [J].World J Urol,2006,24:255- 266.
  • 10Perrotte, U Capitanio, H Isbarn, et al. Nephron - Sparing Surgery Is Equally Effective to Radical Nephreetomy for T1BNOM0 Renal Cell Carcinoma: A Population- Based As sessment[J]. Urology, 2010,75(2) : 271 - 275.

二级参考文献27

  • 1董隽,高江平,徐阿祥,王威,郭刚,朱捷,宋勇,蔡伟,郝通利,洪宝发.不阻断或短时间阻断肾动脉行腹腔镜保留肾单位手术[J].中国微创外科杂志,2007,7(12):1186-1188. 被引量:8
  • 2张大宏,孙文超.保留肾单位的腹腔镜肾肿瘤切除手术方法及技巧[J].中华泌尿外科杂志,2006,27(5):332-334. 被引量:29
  • 3倪伟平,杨波,王林辉,王永军,孙颖浩.逆行肾盂冰水灌注获得肾脏低温的可行性研究[J].中华泌尿外科杂志,2007,28(5):349-349. 被引量:3
  • 4Haber G P, Gill I S. Laparoscopic partial nephrectomy: contemporary technique and outcomes[J]. Eur Urol, 2006,49:660-665.
  • 5Bohon D M,Wong P, Lawrentschuk N. Renal cell carcinoma: imaging and therapy[J]. Curt Opin Urol, 2007,17 : 337-340.
  • 6Filipas D, Fichtner J, Spix C, Black P, Carus W, Hohenfellner R,et al. Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long term outcome in 180 patients[J]. Urology, 2000,56 : 387-392.
  • 7Winfield H N,Donovan J F,Godet A S,Clayman R V. Laparoscopic partial nephrectomy: initial case report for benign disease[J]. J Endourol,1993,7:521-526.
  • 8Moinzadeh A, Gill I S, Finelli A, Kaouk J, Desai M. Laparoscopic partial nephrectomy: 3-year followup[J]. J Urol, 2006,175 : 459-462.
  • 9Gill I S, Matin S F,Desai M M,Kaouk J H,Steinberg A,Mascha E, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients[J]. J Urol,2003,170:64-68.
  • 10Santos Arrontes D,de Castro Barbosa F,Valer Lopez-Fando M P, Fernandez Arjona M,Cortes Aranguez I. Renal cell renal car cinoma. Analysis of incidence and survival in a 90,000 citizens healthcare area[J]. Arch Esp Urol, 2006,59: 233-237.

共引文献41

同被引文献25

  • 1Rini BI,Campbell SC,Eseudier B. Renal cell carcinoma[J]. Lan- cet,2009,373(9669) :1119-1132.
  • 2Li X, Tan X, Yu Y, et al. D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and corre- lates with the down-regulation of protein tyrosine phosphatase receptor delta[J]. Cancer, 2011,117 (18): 4201-4211.
  • 3Crispen PL,Boorjian SA,Lohse CM,et al. Predicting disease pro- gression after nephrectomy for localized renal cell carcinoma the utility of prognostic models and molecular biomarkers[J]. Canc- er,2008,113(3) :450-460.
  • 4Bigot P, Lughezzani G, Karakiewicz P, et al. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality[J]. J Urol, 2010, 183 (2) :486-491.
  • 5Gutwein P,Schramme A,Sinke N,et al. Tumoural CXCL16 expression is a novel progaostic marker of longer survival times in renal cell cancer patients[J]. Eur J Cancer, 2009,45(3):478-489.
  • 6Guo G, Gui Y, Gao S, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma[J]. Nat Genet, 2011,44 ( 1 ) : 17-19.
  • 7Purdue MP,Johansson M, Zelenika D, et al. Genome-wide associ- ation study of renal cell carcinoma identifies two susceptibility lo- ci on 2p21 and llq13.3[J]. Nat Genet,2011,43(1) :60-65.
  • 8Lusk B. Nursing's central role in the care of individuals with cancer: 1900-1940[J]. Oncol Nurs Forum, 2011,38 (Suppl) : E1-E6.
  • 9Ravichandran K, A1-Hamdan NA, Mohamed G. Knowledge, atti- tude,and behavior among Saudis toward cancer preventive prac- tice[J]. J Family Community Med,2011,18(3) :135-142.
  • 10Mbamara SU, Ikpeze OC, Okonkwo JE, et al. Knowledge, attitude and practice of cervical cancer screening among women attending gynecol- ogy clinics in a tertiary level medical care center in southeastern Ni- geria[J]. J Reprod Med,2011,56(11-12) :491-496.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部